News & Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Ken & Ruth Davee Department of Neurology.
Northwestern scientists have created the first highly mature neurons from human induced pluripotent stem cells, a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases.
A new Northwestern Medicine study has discovered the role of cerebrospinal fluid in cognitive impairment, such as Alzheimer’s disease.
- 12.05.2022As 2023 peers around the corner, people will no doubt begin thinking through their lists of New Year’s resolutions. While healthy eating, exercise, budgeting and others are important, cardiology and sleep medicine experts at Northwestern Medicine are encouraging one goal to be on everyone’s lists: getting better sleep.
Genetic testing in epilepsy patients can inform treatment and lead to better outcomes in many cases, according to a study published in JAMA Neurology.
Northwestern physicians, scientists and people living with ALS gathered at the 12th annual Les Turner Symposium on ALS to share knowledge and celebrate advances in understanding and treating the disease.
Investigators have discovered novel genetic factors that contribute to the risk of Parkinson’s disease, according to a recent Northwestern Medicine study.
After 28 years of leadership, M. Marsel Mesulam, MD, has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease; he will be succeeded by Robert Vassar, PhD.
Northwestern Medicine investigators have discovered that outer mitochondrial membrane proteins regulate crosstalk between mitochondria and lysosomes, findings that have implications for many diseases.
Dimitri Krainc, MD, PhD, chair and Aaron Montgomery Ward Professor of Neurology, has been elected to the National Academy of Medicine.
- 09.13.2022Dedicated scientists, physicians, and social workers at Feinberg’s Mesulam Center for Cognitive Neurology and Alzheimer’s Disease are tackling dementia disorders from all angles.
- 08.29.2022People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease. But a Northwestern Medicine study, in collaboration with Institute for Therapy through the Arts (ITA), shows how that gap can be bridged with a new music intervention.
- 08.26.2022The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University Feinberg School of Medicine has been awarded a $10.4 million grant from the National Institute on Aging (NIA) to support the center’s ongoing research on Primary Progressive Aphasia (PPA).
- 07.22.2022Jim Lowry has long been a friend and supporter of Northwestern. At Kellogg School of Management, he serves on the Global Advisory Board and teaches a course focusing on minority and women-owned businesses. He also has served on the board of Northwestern Memorial Hospital. But it was at a small, community-driven event outside of Lake Geneva, Wisconsin, where he first learned of the important work being done at Feinberg to understand and treat Parkinson’s disease.
Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Exposure to light during sleep was associated with obesity, diabetes and high blood pressure in older adults, according to a recent study.
“Everybody has their own Mount Everest they were put on this earth to climb,” said Run4Papa founder Jason Boschan. “Mine is running to find a cure for dementia.”
- 06.27.2022In a sample of older men and women ages 63 to 84, those who were exposed to any amount of light while sleeping at night were significantly more likely to be obese, and have high blood pressure and diabetes compared to adults who were not exposed to any light during the night, reports a new Northwestern Medicine study.
A new cohort of neurologists graduated from the Ken & Ruth Davee Department of Neurology’s residency program in a ceremony held June 17.
In July 2021, Jay Keller wasn’t feeling like himself. The Chicago-based architect, husband and father had fatigue and cold-like symptoms. “I thought maybe I had Lyme disease, COVID-19 or walking pneumonia; I just wasn’t sure,” said 48-year-old Keller. By September, he developed horrible headaches, and was admitted to Northwestern Memorial Hospital for testing. Blood work showed Keller had endocarditis (an infected heart valve) from Streptococcus mutans (oral bacteria) that can cause cavities.
A new Northwestern Medicine study has identified how ketamine works so quickly, and how it might be adapted without side effects.
Investigators have discovered a new method to determine whether individual genetic variants in the epilepsy-associated gene SZT2 cause the neurodevelopmental disorder, according to a Northwestern Medicine study.
On May 21, more than 400 people in the ALS community—including patients, friends, family, advocates, clinicians, and scientists—gathered in-person and virtually to support the Les Turner ALS Foundation and its mission to improve treatments and outcomes for ALS patients worldwide. Together, they contributed nearly $550,000 at this year’s Hope Through Caring Gala, held at the Radisson Blu Aqua Hotel, Chicago.
Ketamine is the speedster of antidepressants, working within hours compared to more common antidepressants that can take several weeks. But ketamine can only be given for a limited amount of time because of its many side effects. Now, a new Northwestern Medicine study identifies for the first time exactly how ketamine works so quickly, and how it might be adapted for use as a drug without the side effects.
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.
As part of the efforts of the Neurosciences Health Equity, Diversity, and Inclusion Committee, neurology faculty and residents have been volunteering their time at the CommunityHealth Clinic in West Town, Chicago, in recent months.
- New study finds persistent viral shedding of COVID-19 is associated with delirium and six-month mortality in hospitalized COVID-19 patients05.11.2022
A new Northwestern Medicine study published in GeroScience sought to determine the prevalence, risk factors and significance of persistent viral shedding in hospitalized COVID-19 patients. The Northwestern Medicine Neuro COVID-19 research team discovered patients who continued to test positive more than 14 days after their initial positive test were more likely to experience delirium, longer hospital stays, were less likely to be discharged home, and had a greater six-month mortality than those without persistent viral shedding of COVID-19.
The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.
The Lou and Jean Malnati Brain Tumor Institute of Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is committed to advancing the understanding and treatment of brain and spine tumors.